Ignite Creation Date:
2024-07-17 @ 10:55 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06477497
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-27
First Post:
2024-06-04
Brief Title:
The Application of Comprehensive Prevention and Treatment Strategy of Placenta Accreta Spectrum Disorders
Sponsor:
Peking Union Medical College Hospital
Organization:
Peking Union Medical College Hospital
Study Overview
Official Title:
The Application of Comprehensive Prevention and Treatment Strategy of Placenta Accreta Spectrum Disorders
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Placenta accreta spectrum PAS disorders are pathological attachment of the placenta to myometrium where trophoblastic cells invade the uterine placental interface PAS can lead to severe postpartum hemorrhage or even maternal death Prenatal diagnosis of PAS is essential for optimal obstetric management to improve the pregnancy outcomes However in some low resource regions in China less than 20 PAS are detected before delivery
To explore the feasibility and universality of the bundled prevention and treatment strategy for placenta accreta spectrum disorders in different levels of medical institutions and to investigate its effectiveness in improving the specialized disease management capabilities of medical institutions at all levels We will conduct a regional cluster-randomized trial to assess a multicomponent PAS management strategy to improve the prepartum detection rate of PAS
To explore the feasibility and universality of the bundled prevention and treatment strategy for placenta accreta spectrum disorders in different levels of medical institutions and to investigate its effectiveness in improving the specialized disease management capabilities of medical institutions at all levels We will conduct a regional cluster-randomized trial to assess a multicomponent PAS management strategy to improve the prepartum detection rate of PAS
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None